Jidong Cheng
- Molecular Biology
- Pharmacology top 10%
- Epidemiology
- Cancer Research
- Hepatology top 10%
- Co-authors
- Hiroyasu ImanishiToshikazu HadaWeidong LiuXubin JingNoboru UekiTakayuki MorisakiHideji NakamuraYoshiki Amuro
- Topics
- Inflammatory mediators and NSAID effects (7 papers)Eicosanoids and Hypertension Pharmacology (3 papers)Metabolism, Diabetes, and Cancer (3 papers)
- Cited by
- ToxicologyHepatologyPharmacology
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of HepatologyInternational Journal of Cancer
- Partner nations
- JapanChinaUnited States
In The Last Decade
Jidong Cheng
31 papers receiving 685 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 280
- Pharmacology 155
- Epidemiology 128
- Cancer Research 93
- Hepatology 83
Countries citing papers authored by Jidong Cheng
This map shows the geographic impact of Jidong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jidong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jidong Cheng more than expected).
Fields of papers citing papers by Jidong Cheng
This network shows the impact of papers produced by Jidong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jidong Cheng. The network helps show where Jidong Cheng may publish in the future.
Co-authorship network of co-authors of Jidong Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Jidong Cheng. A scholar is included among the top collaborators of Jidong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jidong Cheng. Jidong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 48 | |
| 4 | 32 | |
| 5 | 14 | |
| 6 | 15 | |
| 7 | 66 | |
| 8 | 9 | |
| 9 | 13 | |
| 10 | 28 | |
| 11 | 7 | |
| 12 | 8 | |
| 13 | 14 | |
| 14 | 24 | |
| 15 | 66 | |
| 16 | 85 | |
| 17 | 11 | |
| 18 | 10 | |
| 19 | 46 | |
| 20 | 1 |
About Jidong Cheng
Jidong Cheng is a scholar working on Nephrology, Pharmacology and Biochemistry, having authored 31 papers that have together received 702 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Toxicology (37 citations), Hepatology (83 citations) and Pharmacology (155 citations). Jidong Cheng has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Hiroyasu Imanishi, Toshikazu Hada, Weidong Liu, Xubin Jing, Noboru Ueki, Takayuki Morisaki, Hideji Nakamura, Yoshiki Amuro, Toshikazu Hada and Hiroko Morisaki. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Hepatology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.